Douglas Lane & Associates’s Nucor NUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51.8M Sell
232,647
-11,330
-5% -$2.56M 0.7% 60
2026
Q1
$41.3M Sell
243,977
-7,010
-3% -$1.22M 0.59% 71
2025
Q4
$40.9M Sell
250,987
-460
-0.2% -$69.1K 0.56% 78
2025
Q3
$34.1M Buy
251,447
+4,601
+2% +$651K 0.47% 83
2025
Q2
$32M Buy
246,846
+15,375
+7% +$1.8M 0.46% 85
2025
Q1
$27.9M Buy
231,471
+26,607
+13% +$3.43M 0.41% 91
2024
Q4
$23.9M Buy
204,864
+107,296
+110% +$15.4M 0.34% 96
2024
Q3
$14.7M Buy
97,568
+18,044
+23% +$2.71M 0.2% 105
2024
Q2
$12.6M Buy
79,524
+3,030
+4% +$526K 0.18% 110
2024
Q1
$15.1M Buy
76,494
+2,560
+3% +$468K 0.21% 106
2023
Q4
$12.9M Buy
73,934
+17,919
+32% +$2.84M 0.2% 107
2023
Q3
$8.76M Buy
56,015
+29,241
+109% +$4.84M 0.15% 113
2023
Q2
$4.39M Buy
+26,774
New +$3.91M 0.07% 121

Other funds holding NUE

Douglas Lane & Associates's NUE Position: Q2 2026 in Review

Douglas Lane & Associates reduced its Nucor (NUE) stake by 4.6% in Q2 2026, selling an estimated $2.56M and leaving 232,647 shares worth $51.8M. The position accounts for 0.7% of the portfolio, ranked #60.

Douglas Lane & Associates first reported a position in NUE in Q2 2023 and has held it in 13 quarters since. 463 funds tracked by Wall St. Rank hold NUE as of Q2 2026.

  • Douglas Lane & Associates held 232,647 shares of Nucor worth $51.8M as of Q2 2026.
  • Douglas Lane & Associates sold 11,330 Nucor shares in Q2 2026, an estimated $2.56M.
  • Nucor made up 0.7% of Douglas Lane & Associates's portfolio in Q2 2026, its #60 holding.
  • Douglas Lane & Associates first reported a position in Nucor in Q2 2023 and has held it in 13 quarters since.
  • 463 funds tracked by Wall St. Rank held Nucor as of Q2 2026.

Based on Douglas Lane & Associates's 13F filing for Q2 2026, filed 14 Jul 2026.